Kiora Pharmaceuticals, Inc.

KPRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$3,792$2,455$5,965$7,855
Short-Term Investments$23,000$0$0$0
Receivables$601$2,050$1,373$530
Inventory$0$0$0$0
Other Curr. Assets$2,313$233$343$607
Total Curr. Assets$29,706$4,738$7,681$8,991
Property Plant & Equip (Net)$62$115$172$283
Goodwill$0$0$0$0
Intangibles$0$8,814$10,743$10,768
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$6,716$45$82$88
Total NC Assets$6,778$8,974$10,998$11,140
Other Assets$0$0$0$0
Total Assets$36,484$13,712$18,678$20,130
Liabilities
Payables$416$206$1,008$161
Short-Term Debt$23$47$106$119
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,570$1,381$2,158$1,330
Total Curr. Liab.$6,009$1,634$3,272$1,610
LT Debt$34$60$0$91
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$779$689$802
Other NC Liab.$4,682$5,129$3,309$3,049
Total NC Liab.$4,716$5,968$3,998$3,942
Other Liabilities$0$0$0$0
Cap. Leases$57$107$106$209
Total Liabilities$10,725$7,602$7,271$5,551
Equity
Pref Stock$0$0$0$0
Common Stock$268$77$18$3
Retained Earnings-$143,382-$146,977-$134,463-$120,879
AOCI-$282-$183-$183-$86
Other Equity$169,156$153,192$146,035$135,542
Total Equity$25,760$6,110$11,408$14,579
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$36,484$13,712$18,678$20,130
Net Debt-$3,735-$2,348-$5,859-$7,645